Adhesion Barriers Market Report by Product, Formulation, Application, Countries and Company Analysis 2026-2034

The Adhesion Barriers Market was valued at US$ 1.27 billion in 2025 and is estimated to reach US$ 2.15 billion by 2034 at a CAGR of 6.03% during the forecast period from 2026 to 2034. Factors such as the rising incidence of surgical procedures, increasing awareness regarding post-operative complications, and a growing preference for minimally invasive surgeries are contributing towards the growth of the market.

Adhesion Barriers Market Outlook

Adhesion barriers are medical devices that are applied in surgeries to avoid the development of adhesions in the body. Adhesions are bands of scar tissue that may form among organs and tissues in the body following surgical procedures. The development of adhesions may cause a variety of complications including chronic abdominal pain, infertility in women, bowel obstruction, and necessitate recurrent surgeries. Adhesion barriers are applied in the body in the form of films, gels, fluids, or sprays. They serve to create a distance among tissues in the body during the healing phases and are bioresorbable; they are readily absorbed in the body once the healing process is complete.

Globally, the adoption of adhesion barriers has seen a substantial rise owing to the rising number of abdominal, pelvic, gynecological, and cardiovascular surgeries. The increasing awareness of the long-term clinical and economic burden of surgical adhesions among surgeons has promoted the adoption of adhesion barriers. The medical field has seen tremendous progress in terms of the development of biomaterials used to manufacture adhesion barriers. The rising trend of adopting minimal access surgeries globally has also contributed to the adoption of adhesion barriers. With the focus of healthcare systems shifting to better patient outcomes and preventing complications following surgeries, adhesion barriers adoption is on the rise in the developed as well as the developing markets.

Growth Drivers for the Adhesion Barriers Market

Rising Volume of Surgical Procedures Worldwide

Tens of millions of people are treated surgically every year, and surgical interventions are estimated to account for 13% of the world’s total DALYs. Thus, the increasing number of surgeries being carried out across the world is one of the prime growth promoters for the adhesion barriers market. Intra-abdominal, pelvic, gynecological, orthopedic, and cardiovascular surgeries are rising due to the growth in chronic diseases, an aging population, and improved access to healthcare services. These procedures are commonly associated with post-surgical adhesions as a complication that causes pain, infertility, bowel obstruction, and repeat surgeries. In a bid to limit post-operative risks and improve long-term patient outcomes, health providers are increasing the application of adhesion barriers. In this regard, surgeons are increasingly fronting preventive measures rather than managing complications related to adhesions later.

Growing Awareness of Adhesion-Related Complications

An increased awareness regarding the clinical and economic impact of surgical adhesions, among surgeons and medical institutions, is a key contributor to the growth of the market. Surgical adhesions can lead to serious long-term consequences, which can severely impact the quality of life of patients and lead to frequent hospitalizations. Medical education, research, and professional society guidelines persistently emphasize the advantages of preventing surgical adhesions during surgical procedures. This has led to an increased probability of surgeons including adhesion barriers in their routine surgical procedures. Medical institutions also understand the economic advantages of prevention over dealing with complications caused by surgical adhesions. In a BeNeFIT project, which was a collaboration between ZonMW and KCE, grants were allocated to three Radboud University Medical Center projects in May 2024. Large-scale clinical trials are being conducted in a number of hospitals spread across Belgium and the Netherlands, forming part of all three initiatives. They mainly cover areas like critical care, surgery, and psychiatry.

Advancements in Biomaterials and Product Innovation

Advances in technology relating to biomaterials and product design are fueling the growth of the adhesion barrier market. Companies are working on the development of next-generation adhesion barriers that have better biocompatibility, ease of use, and effectiveness. New products in development include bioresorbable gels, sprays, and films that better conform to complex surgical sites and have compatibility with MIP. The newer products have faster application times and better surgeon ease-of-use confidence. Improved safety profiles and fewer risks of inflammation or infection further contribute to their adoption. Ongoing R&D work is increasing the scope of surgical use for adhesion barriers. As technology advances and improves use and outcomes in surgery, healthcare professionals are more likely to use the technology, and the market is expected to continue to grow. Osaka-Gunze Limite is delighted to announce that Gunze has received approval to market and distribute medical devices to manufacture and sell the first sheet-type absorbable adhesion barrier in Japan, “TENALEAF™.” The product is slated to be launched in March 2022 in the Japanese market by its subsidiary “Gunze Medical Japan.”

Challenge in the Adhesion Barriers Market

High Cost and Limited Reimbursement

One of the significant factors hindering the growth of the market for adhesion barriers is the relatively high costs of products. These products are supplementary health care costs, which may or may not be reimbursed by health care systems, depending on their financial priorities. There may also be fiscal priorities among health care systems, such that essential surgical instruments are preferred to supplementary health care instruments such as adhesion barriers. Among fiscal priorities, there may also be health care priorities, such that health care instruments are not used due to their cost, despite their health care advantages.

Variability in Clinical Effectiveness and Adoption

Variability of clinical results and uneven adoption rates within specific surgical disciplines are also considered another hurdle. Efficacy of adhesiology barriers may depend on various factors, including surgical methods and proper utilization. Moreover, discrepancies in clinical results may provoke doubts about adopting these barriers in surgical procedures for preventing adhesions. Furthermore, the absence of common protocols for all types of surgical disciplines may also decrease adoption rates. Some surgeons are preferring conventional methods rather than adopting innovative methods for preventing adhesions.

Synthetic Adhesion Barriers Market

The synthetic adhesion barriers market is mainly propelled by the rising demand for engineered biomaterials, which have demonstrated properties concerning effective adhesion barrier functions. Additionally, adhesion barriers made of synthetic biomaterials are generally processed from synthetic polymers, which create a physical barrier between tissue types at a critical period after surgery. Surgeons rely on synthetic adhesion barriers, which demonstrate standardized properties concerning their degradation velocities and smooth handling. In comparison with biologic adhesions, surgeons consider synthetic adhesions less risky concerning infections. In addition, there is an increasing trend towards using synthetic adhesions within typical methodologies related to surgery. Advancements within polymer technology support improved flexibility, resistance, and biocompatibility. Consequently, there is increasing popularity among surgeons concerning handling, facilitating effective adhesions. In addition, healthcare platforms adopting standardized methodologies related to effective surgical operations continue to promote increasing application of synthetic adhesions within various surgery platforms worldwide.

Liquid Adhesion Barriers Market

The liquid adhesion barriers market is experiencing an upward trend owing to the increasing demand for easily applicable and non-invasive methods. Liquid adhesion barriers can simply be sprayed or poured on the surgical site to provide a thin protective coat, which molds according to complex anatomical structures. Thus, these adhesion barriers can prove to be an efficient option in laparoscopic and minimally invasive surgery, where accurate positioning of the paste adhesion barriers might not be possible. The increasing demand in the gynecological, abdominal, and overall surgical procedures related to minimally invasive surgeries has accelerated the demand for liquid adhesion barriers. Innovations in the liquid adhesion barriers material have improved the viscoelastic properties and bioresorption, thus increasing their demand in the surgical markets. With surgeons looking out for an efficient and flexible means to prevent adhesion, the demand for liquid adhesion barriers will continue to grow in the surgical markets.

Gel Adhesion Barriers Market

The versatility and strong clinical acceptance have given momentum to the gel adhesion barriers market. Gel-based barriers effectively separate tissues, flexible, and adhere well to irregular surgical surfaces. These are particularly effective in preventing adhesions in sensitive and high-risk surgical areas, including pelvic and abdominal regions. Gels are easy to apply, have good visibility intraoperatively, and tend to remain localized without significant risk of displacement from the application site. The newer formulations have enhanced biocompatibility with reduced inflammatory responses, thereby improving surgeons' confidence in their use. Gel adhesion barriers are compatible both with open and minimally invasive procedures, which makes them widely applicable across surgical disciplines. With increasing demand for reliable, user-friendly solutions to prevent adhesions, the gel-based products are positioned to continue exhibiting strong market growth.

Adhesion Barriers Gynecological Surgeries Market

Driven by the number of cases of adhesions that occur after procedures such as hysterectomy, myomectomy, and endometriosis surgery, the adhesions barriers for gynecological surgery market has grown in demand. Additionally, the risks associated with adhesions in females, including infertility, chronic pelvic pain, and recurrent surgeries, have driven the adoption of these barriers during gynecological surgery procedures. An increase in the adoption of minimally invasive gynecologic surgery, which offers an ideal market for innovative adhesions barrier products that allow for accurate placement, will continue to drive the market for adhesions barriers for gynecological surgery during the forecast period. Furthermore, focusing on the growing interest in women's health, the market for adhesions barriers for gynecological surgery will continue to expand.

Adhesion Barriers Orthopedic Surgeries Market

The adhesion barriers in orthopedic surgery market is growing in response to the need to minimize post-operative complications such as adhesion formation, stiffness, and reduced mobility. In orthopedic surgery, there are potential risks to the formation of adhesions from surgery in joints, tendons, and spines. The use of adhesion barriers supports better tissue plane maintenance and can contribute to improved outcomes from surgery. The growing number of orthopedic surgeries, due to an aging population, sports injuries, and degenerative diseases, is increasing demand. The improvements in materials used in adhesion barriers have enhanced biocompatibility with tissues in the musculoskeletal system. The increasing desire of patients for rapid improvements in mobility post-operatively is propelling adhesion barriers into prominence in orthopedic surgery.

United States Adhesion Barriers Market

The United States Adhesion Barriers market is among the most developed and well-established ones worldwide, driven by high surgical volume and high awareness levels for post-operative complications. High numbers of abdominal, gynecological, orthopedic, and cardiovascular surgeries are being done each year, thus fueling a growing need for adhesion barriers. Many surgeons in the United States have adopted adhesion barriers routinely as a part of standard surgical practice to provide enhanced patient outcomes. Advanced healthcare infrastructure, early adoption of cutting-edge technological materials, and concrete scientific data all provide support for enhanced market growth. Reimbursement support for key surgical procedures, as well as strong market presence for top-class medical device companies, further increase the same. Sep 2025, Womed, the company for women's uterine health, that focuses on developing unique intrauterine therapeutic solutions aimed at freeing women from the hold of uterine pathologies, announced that it has obtained the Food & Drug Administration's PreMarketing Approval for the PreMarketing Approval submission for its breakthrough innovation, the "Womed Leaf" for adult women who undergo hysteroscopic surgery for symptomatic, moderate to severely altered intrauterine adhesions, also known as "Asherman syndrome".

United Kingdom Adhesion Barriers Market

The UK adhesion barriers market is a steadily growing market due to increasing awareness of adhesion complications and the rise in surgical procedures in the National Health Service. Gynecological and abdominal surgery contribute largely to the growing demand for adhesion barriers since preventing adhesions has a profound effect on patient results. Effective government regulation has ensured that the quality of the products manufactured meets a high standard. Additionally, the increase in less invasive surgery has led to the rise in demand for more sophisticated forms of barriers in the UK adhesion barrier market. Cost control in the public medical system has not had a largely positive effect on widespread acceptance in the UK market since there is a drive towards preventing repeat surgeries in order to control long-term healthcare expenses. May 2024 saw BD announce the latest version of its Interceed adhesion barrier film for use in gynecological and abdominal surgery through the increasing use of minimally invasive techniques in Europe, including the UK.

India Adhesion Barriers Market

The India adhesion barriers market is growing rapidly owing to increasing surgical volumes, improvement in healthcare infrastructure, and growing awareness among surgeons. Also, the increase in the prevalence of chronic diseases and expansion of access to gynecological and abdominal surgeries are some of the demand drivers. Private hospitals and specialty surgical centers are the major contributors to adoption, especially in urban cities. However, cost sensitivity and limited reimbursement remain the challenges, therefore restricting usage to complex or high-risk procedures. Growing medical tourism and investments in advanced surgical technologies have positively influenced the growth of this market. Strong clinician education and available affordable product options will expand adoption of adhesion barriers. India is a high-growth opportunity owing to its large patient base and ongoing modernization of healthcare.

Saudi Arabia Adhesion Barriers Market

The Saudi Arabia adhesion barrier market is growing steadily. The major reason is the rising number of surgical procedures and increasing investments made by the Saudi government in the field of healthcare infrastructure. Increasing awareness regarding the complications that can arise after surgery and better patient outcomes due to the use of adhesion prevention products are motivating the adoption of adhesion barrier products. The expenditure on the healthcare system and advancements in medical technology allow many hospitals to adopt new products in the field of adhesion barriers. Gynecological surgery, orthopedic surgery, and abdominal surgery represent some of the major segments that contribute to the growing demand for adhesion barrier products. The development of private healthcare facilities and surgical centers is also contributing to the rising adoption of adhesion barrier products in the market.

Market Segmentation

Product

• Synthetic
• Natural

Formulation

• Film
• Liquid
• Gel

Application

• Gynecological Surgeries
• General/Abdominal Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Reconstructive Surgeries
• Urological Surgeries
• Others

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All companies have been covered with 5 Viewpoints

• Overview
• Key Persons
• Recent Development & Strategies
• Product Portfolio
• Financial Insights

Company Analysis

• Anika Therapeutics, Inc.
• Baxter International, Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Medtronic Plc
• Medical Devices Business Services, Inc.
• Groupe Sanofi